<DOC>
	<DOCNO>NCT00263601</DOCNO>
	<brief_summary>The trial perform assess efficacy safety Grass Pollen Allergoid Allergic Rhinoconjunctivitis</brief_summary>
	<brief_title>Safety Efficacy Grass Pollen Allergoid Treatment Allergic Rhinoconjunctivitis</brief_title>
	<detailed_description>Pollen allergoids prepare chemical modification partially purify native allergen aqueous extract deplete component molecular mass less 5000 Daltons diafiltration . Clinical study show good tolerance aqueous grass , ragweed tree pollen allergoids comparison allergen preparation . Adsorption pollen allergoids onto aluminium hydroxide suspension result depot preparation investigate series clinical study show well tolerate good clinical efficacy . Depot pollen-allergoids introduced German market 1987 trade name Allergovit® firmly establish recommend primarily shortcourse preseasonal immunotherapy pollinosis . Allergovit® currently available many European non-European country . A placebo-controlled study design choose improvement symptom pollen allergy show time , pollen season different year comparable . Due different mechanism action , specific immunotherapy compare anti-allergic drug . Thus chance prove efficacy specific immunotherapy ( SIT ) test versus parallel placebo group .</detailed_description>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<mesh_term>Hypersensitivity</mesh_term>
	<criteria>Positive Skin Prick test grass pollen Positive RAST grass pollen Positive specific provocation test grass pollen Serious chronic diseases Other perennial allergy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Allergovit</keyword>
	<keyword>Grass pollen allergy</keyword>
</DOC>